speb/financial-data huggingface dataset:
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 95400000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 28441423.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 9.56
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — EBIT: 412000000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — EBITDA: 507400000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 1135300000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1520500000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2887900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1248400000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 48600000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 48600000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 2245100000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7968100000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 333200000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 53500000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 760600000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 814100000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 20400000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 54800000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -2300000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2214900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 274200000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 274200000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -48600000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -48600000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2887900000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4138300000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 53300000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 507400000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 271900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Operating Income: 365700000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2406700000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 28442606.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 325000000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 197000000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 5601900000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 385200000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 139600000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 46300000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 575100000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2623800000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 8300000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 429900000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1972100000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 363400000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1158300000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 95400000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 28442606.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5658800000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4138300000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 89200000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 630000000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 10455600000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6419400000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2405400000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5713600000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2041000000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4742000000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4885700000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 887800000.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 803300000.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CARYSIL.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CARYSIL.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1715700000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 894000000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2225700000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 28448043.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 7.41
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1005100000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 95200000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 95200000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 28448043.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 7.41
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 210800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — EBIT: 341400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — EBITDA: 436600000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1220600000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 47400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 47400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -1800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income: 210800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 210800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 212600000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 210800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 210800000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 212600000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -47400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -47400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 447900000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 218971360.54
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Operating Income: 326600000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2225700000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 26100000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 577000000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 294000000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1005100000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 95200000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -11300000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -3128639.46
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 81400000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1899100000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -11300000.00
CARYSIL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -11300000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — +Operating Expense: 3579500000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 953100000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9239500000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2337200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1015900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1015900000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1607400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1607400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 50300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 50300000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 28466387.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 9.52
CARYSIL.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 128500000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1114900000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 129200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 129200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 56900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 56900000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 76300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 76300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 641300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 641300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -68600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -379700000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -48100000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -62200000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Payable: 247700000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -106100000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -334400000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -52200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Common Stock: 56900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 56900000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -68600000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6084200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6084200000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 13300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 252900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 252900000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4283900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1044400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5213200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5213200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 44200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 44200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Debt: 2224900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 2224900000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2269100000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2269100000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 3616800000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3616800000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 25400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 25400000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 309300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Depreciation: 395600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 395600000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 395600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 110600000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 395600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 110600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 28466387.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 9.52
CARYSIL.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 981900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 271000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — EBIT: 1496000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — EBIT: 385900000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — EBITDA: 1891600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — EBITDA: 496500000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — End Cash Position: 76300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -246900000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -28200000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -700000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Goodwill: 1138400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 1138400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1532200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1532200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 3508000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3508000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Gross Profit: 4955600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1292800000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Interest Expense: 197000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 47600000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 197000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 47600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -197800000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 37400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Inventory: 2591100000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2591100000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8780400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8780400000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -892000000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 50300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 50300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 13300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 463000000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 85000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 85000000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 471300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 471300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 556300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 556300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 463000000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -421300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 27500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 27500000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 59300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 59300000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Minority Interests: -7800000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -2800000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 13300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2619900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2619900000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -113900000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income: 981900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income: 271000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 981900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 271000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 989700000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 273800000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 981900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 271000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 981900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 271000000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 989700000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 989700000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 273000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Interest Income: -197000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -47600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 183100000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 41700000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 41700000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -197000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -47600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 3300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Net PPE: 3508000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 3508000000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1111700000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4552000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4552000000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 77700000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 77700000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1902900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 496500000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Normalized Income: 990509399.54
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 271000000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1086700000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Operating Income: 1376100000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Operating Income: 339700000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9239500000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2337200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 28442606.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 28442606.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 361400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 361400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 157900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 157900000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6027300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6027300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 393800000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 393800000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 159600000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 114600000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 114600000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 7500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 7500000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 131200000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 46200000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2296600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 611300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3255100000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3255100000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 6500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 6500000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 565000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 565000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Payables: 1109800000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1109800000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Pretax Income: 1299000000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 338300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3100000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1114900000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 4283900000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1044400000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 395600000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 110600000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -421300000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 186200000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 3200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 28442606.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 28442606.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Special Income Charges: -11300000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 0.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 6084200000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6084200000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4552000000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4552000000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -2690600.46
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Tax Provision: 309300000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 64500000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 5500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 5500000.00
CARYSIL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -328100000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 10421800000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 10421800000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 6555500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6555500000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2825400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2825400000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 6143500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6143500000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Total Expenses: 7863400000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1997500000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4278300000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4278300000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 5208600000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5208600000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 661500000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 661500000.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 93900000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 93900000.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -11300000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CARYSIL.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -11300000.00
CARYSIL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CARYSIL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1596400000.00
CARYSIL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1596400000.00
CAS.TO income_statement (annual, 2021-12-31) — Amortization: 252000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 252000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 252000000.00
CAS.TO income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 252000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Cash Flow From Discontinued Operation: 356000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: -12000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Change In Tax Payable: -12000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
CAS.TO cash_flow (annual, 2021-12-31) — Common Stock Payments: -26000000.00
CAS.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 40000000.00
CAS.TO income_statement (annual, 2021-12-31) — Interest Income: 1000000.00
CAS.TO income_statement (annual, 2021-12-31) — Interest Income Non Operating: 1000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
CAS.TO cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: -26000000.00
CAS.TO income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 234000000.00
CAS.TO income_statement (annual, 2021-12-31) — Other Gand A: 55000000.00
CAS.TO income_statement (annual, 2021-12-31) — Other Special Charges: 20000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -26000000.00
CAS.TO income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 16000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -11000000.00
CAS.TO cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CAS.TO income_statement (annual, 2022-12-31) — +Operating Expense: 1486000000.00
CAS.TO income_statement (annual, 2022-12-31) — +Total Revenue: 4466000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 532000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 525000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2675000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -4000000.00
CAS.TO income_statement (annual, 2022-12-31) — Amortization: 252000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 252000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 252000000.00
CAS.TO income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 252000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 102000000.00
CAS.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 100647972.00
CAS.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.34
CAS.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 174000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1152000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -506000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 208000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 611000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 102000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 111000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -48000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 272000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -486000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 144000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Discontinued Operation: 0.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: -12000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -14000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -69000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Payable: -26000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -26000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -21000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Tax Payable: -14000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -116000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -30000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -70000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Common Stock: 611000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -48000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1871000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -9000000.00
CAS.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 2836000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 136000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Assets: 1265000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 54000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Debt: 83000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 137000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 917000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 80000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -22000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -22000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 40000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 252000000.00
CAS.TO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 252000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 252000000.00
CAS.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 252000000.00
CAS.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 101092352.00
CAS.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.34
CAS.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -34000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 12000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 6000000.00
CAS.TO income_statement (annual, 2022-12-31) — EBIT: 41000000.00
CAS.TO income_statement (annual, 2022-12-31) — EBITDA: 293000000.00
CAS.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 19000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -19000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -2000000.00
CAS.TO cash_flow (annual, 2022-12-31) — End Cash Position: 102000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 272000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 238000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -362000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 6000000.00
CAS.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -15000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 34000000.00
CAS.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 992000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Goodwill: 487000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 561000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 529000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 5620000000.00
CAS.TO income_statement (annual, 2022-12-31) — Gross Profit: 1630000000.00
CAS.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 98000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 4000000.00
CAS.TO income_statement (annual, 2022-12-31) — Interest Expense: 77000000.00
CAS.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 77000000.00
CAS.TO income_statement (annual, 2022-12-31) — Interest Income: 0.00
CAS.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
CAS.TO cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -87000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Inventory: 587000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 3731000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -486000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 4000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 101000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 25000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 69000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 680000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 117000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Line Of Credit: 3000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 154000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 1777000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1931000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 678000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -336000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 94000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 41000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3992000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 57000000.00
CAS.TO income_statement (annual, 2022-12-31) — Minority Interests: -20000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 1000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -9000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Net Debt: 1758000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 9000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income: -34000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -34000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -14000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -34000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -34000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -34000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -14000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -5000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Interest Income: -79000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 344000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 342000000.00
CAS.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -79000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -16000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Net PPE: 2945000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -482000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 2000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1310000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 114000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 132000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 114000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 132000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 8000000.00
CAS.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 413000000.00
CAS.TO income_statement (annual, 2022-12-31) — Normalized Income: 54548000.00
CAS.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 144000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -4000000.00
CAS.TO income_statement (annual, 2022-12-31) — Operating Income: 144000000.00
CAS.TO income_statement (annual, 2022-12-31) — Operating Revenue: 4466000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 100361627.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 80000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 22000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 34000000.00
CAS.TO income_statement (annual, 2022-12-31) — Other Income Expense: -101000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 74000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Investments: 3000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 82000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 19000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 104000000.00
CAS.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 242000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Properties: 359000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 31000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 9000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Payables: 542000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 678000000.00
CAS.TO income_statement (annual, 2022-12-31) — Pretax Income: -36000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CAS.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -36000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -501000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 349000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Receivables: 567000000.00
CAS.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2836000000.00
CAS.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 252000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -336000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -9000000.00
CAS.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 3000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 1212000000.00
CAS.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 992000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 1000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 19000000.00
CAS.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 992000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Share Issued: 100361627.00
CAS.TO cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 2000000.00
CAS.TO income_statement (annual, 2022-12-31) — Special Income Charges: -105000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1871000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1310000000.00
CAS.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -31452000.00
CAS.TO income_statement (annual, 2022-12-31) — Tax Provision: -22000000.00
CAS.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CAS.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 11000000.00
CAS.TO cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -5000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Assets: 5053000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 3648000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Debt: 2068000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1928000000.00
CAS.TO income_statement (annual, 2022-12-31) — Total Expenses: 4322000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3125000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3788000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2208000000.00
CAS.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 33000000.00
CAS.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 2000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4000000.00
CAS.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -120000000.00
CAS.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -120000000.00
CAS.TO balance_sheet (annual, 2022-12-31) — Working Capital: 348000000.00
CAS.TO income_statement (annual, 2022-12-31) — Write Off: 4000000.00
CAS.TO income_statement (annual, 2023-12-31) — +Operating Expense: 1623000000.00
CAS.TO income_statement (annual, 2023-12-31) — +Total Revenue: 4638000000.00
CAS.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 502000000.00
CAS.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 431000000.00
CAS.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2800000000.00
CAS.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15000000.00
CAS.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -7000000.00
CAS.TO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 19000000.00
CAS.TO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 19000000.00
CAS.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 209000000.00